Furthermore, a positive correlation exists between expression of DcR3 and the severity of pancreatic carcinoma, colorectal cancer, breast, cervical, and ovarian cancers (89–93). This evidence concerns the gene TNFRSF6B and exocrine pancreatic carcinoma.